Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Brand

Showing results (21-30 of 124) with videos related to

Pageof 13
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 12, 2009
Impact of renin-angiotensin-aldosterone blockade by angiotensin-converting enzyme inhibitors or AT-1 blockers on frequency of contrast medium-induced nephropathy: a post-hoc analysis from the Dialysis-versus-Diuresis (DVD) trialDaniela Kiski, Wibke Stepper, Eva Brand, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 30, 2024
Relevance of Neutralizing Antibodies for the Pharmacokinetics of Pegunigalsidase Alfa in Patients with Fabry DiseaseMalte Lenders, Elise Raphaela Menke, Michael Rudnicki, et al.
International Journal of Molecular Sciences|June 26, 2026
Identification of Potential Proteins Interacting with α-Galactosidase A to Analyze the Pathogenesis of Fabry DiseaseElise Raphaela Menke, Jürgen Eirich, Iris Finkemeier, et al.
Journal of Hypertension|March 27, 2003
An epidemiological study of blood pressure and metabolic phenotypes in relation to the Gbeta3 C825T polymorphismEva Brand, Ji-Guang Wang, Stefan-Martin Herrmann, et al.
Bioprocess and Biosystems Engineering|March 5, 2013
Enzyme-based glucose delivery: a possible tool for biosorbent preparation for heavy metal removal from polluted environmentsMihaela Palela, Gabriela Elena Bahrim, Julia Glazyrina, et al.
Bioprocess and Biosystems Engineering|May 30, 2018
Importance of the cultivation history for the response of Escherichia coli to oscillations in scale-down experimentsEva Brand, Stefan Junne, Emmanuel Anane, et al.
Nephron. Clinical Practice|April 4, 2013
Impact of peripheral arterial occlusive disease on the development of contrast medium-induced acute kidney injuryFlorian Lüders, Nasser Malyar, Matthias Meyborg, et al.
International Journal of Cardiology|July 13, 2016
Elevated copeptin is a prognostic factor for mortality even in patients with renal dysfunctionChristiane Engelbertz, Eva Brand, Manfred Fobker, et al.
Scientific Reports|March 11, 2018
ZFP226 is a novel artificial transcription factor for selective activation of tumor suppressor KIBRAKatrin Schelleckes, Boris Schmitz, Malte Lenders, et al.
Journal of the American Society of Nephrology : JASN|May 3, 2015
Serum-Mediated Inhibition of Enzyme Replacement Therapy in Fabry DiseaseMalte Lenders, Jörg Stypmann, Thomas Duning, et al.
Pageof 13

Showing results (21-30 of 124) with videos related to

Sort By:
Pageof 13
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 12, 2009
Impact of renin-angiotensin-aldosterone blockade by angiotensin-converting enzyme inhibitors or AT-1 blockers on frequency of contrast medium-induced nephropathy: a post-hoc analysis from the Dialysis-versus-Diuresis (DVD) trialDaniela Kiski, Wibke Stepper, Eva Brand, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 30, 2024
Relevance of Neutralizing Antibodies for the Pharmacokinetics of Pegunigalsidase Alfa in Patients with Fabry DiseaseMalte Lenders, Elise Raphaela Menke, Michael Rudnicki, et al.
International Journal of Molecular Sciences|June 26, 2026
Identification of Potential Proteins Interacting with α-Galactosidase A to Analyze the Pathogenesis of Fabry DiseaseElise Raphaela Menke, Jürgen Eirich, Iris Finkemeier, et al.
Journal of Hypertension|March 27, 2003
An epidemiological study of blood pressure and metabolic phenotypes in relation to the Gbeta3 C825T polymorphismEva Brand, Ji-Guang Wang, Stefan-Martin Herrmann, et al.
Bioprocess and Biosystems Engineering|March 5, 2013
Enzyme-based glucose delivery: a possible tool for biosorbent preparation for heavy metal removal from polluted environmentsMihaela Palela, Gabriela Elena Bahrim, Julia Glazyrina, et al.
Bioprocess and Biosystems Engineering|May 30, 2018
Importance of the cultivation history for the response of Escherichia coli to oscillations in scale-down experimentsEva Brand, Stefan Junne, Emmanuel Anane, et al.
Nephron. Clinical Practice|April 4, 2013
Impact of peripheral arterial occlusive disease on the development of contrast medium-induced acute kidney injuryFlorian Lüders, Nasser Malyar, Matthias Meyborg, et al.
International Journal of Cardiology|July 13, 2016
Elevated copeptin is a prognostic factor for mortality even in patients with renal dysfunctionChristiane Engelbertz, Eva Brand, Manfred Fobker, et al.
Scientific Reports|March 11, 2018
ZFP226 is a novel artificial transcription factor for selective activation of tumor suppressor KIBRAKatrin Schelleckes, Boris Schmitz, Malte Lenders, et al.
Journal of the American Society of Nephrology : JASN|May 3, 2015
Serum-Mediated Inhibition of Enzyme Replacement Therapy in Fabry DiseaseMalte Lenders, Jörg Stypmann, Thomas Duning, et al.
Pageof 13